Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 0 | 145 | 3,185 | 0 | 0 |
| Gross Profit | N/A | 145 | 3,185 | N/A | N/A |
| Operating Expenses | 36,432 | 57,322 | 38,428 | 28,459 | 28,247 |
| Operating Income | -36,432 | -57,177 | -35,243 | -28,459 | -28,247 |
| Interest Expense | 0 | 0 | 0 | 1,049 | 2,599 |
| Other Income | 9,558 | 1,654 | 23 | -96 | -15 |
| Pre-tax Income | -26,874 | -55,523 | -35,220 | -29,604 | -30,861 |
| Net Income Continuous | -26,874 | -55,523 | -35,220 | -29,604 | -30,861 |
| Net Income | $-26,874 | $-55,523 | $-35,220 | $-29,604 | $-30,861 |
| EPS Basic Total Ops | -2.86 | -12.87 | -7.91 | -10.88 | -13.52 |
| EPS Basic Continuous Ops | -2.61 | -10.75 | -7.91 | -10.88 | -13.52 |
| EPS Diluted Total Ops | -2.86 | -12.87 | -7.91 | -10.88 | -13.52 |
| EPS Diluted Continuous Ops | -2.61 | -10.75 | -7.91 | -10.88 | -13.52 |
| EPS Diluted Before Non-Recurring Items | -3.75 | -12.88 | -7.92 | -10.88 | -13.36 |
| EBITDA(a) | $-36,151 | $-56,911 | $-34,958 | $-27,670 | $-26,725 |